Trial Profile
A Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Acne; Acne vulgaris
- Focus Therapeutic Use
- Acronyms OPAL
- Sponsors BioPharmX Corporation
- 19 Jul 2018 According to a BioPharmX Corporation media release, data from this trial will be presented at the Dermatology Education Foundation's DERM2018 conference.
- 11 Oct 2017 According to a BioPharmX Corporation media release, data will be presented at the 2017 Fall Clinical Dermatology Conference.
- 13 Jul 2017 According to a BioPharmX Corporation, results will be presented at the Dermatology Education Foundation's Essential Resource Meeting, DERM 2017.